Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
OSIR > SEC Filings for OSIR > Form 8-K on 6-Dec-2013All Recent SEC Filings

Show all filings for OSIRIS THERAPEUTICS, INC.

Form 8-K for OSIRIS THERAPEUTICS, INC.


6-Dec-2013

Change in Directors or Principal Officers


ITEM 5.02. Departures of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

On December 2, 2013, C. Randal Mills, who has served as President and Chief Executive Officer of the Company since May 2004, resigned for personal reasons, effective the following day. Upon Dr. Mill's departure, Lode Debrabandere, the Company's Chief Operating Officer, assumed the additional roles of President and Chief Executive Officer, pending confirmation by the Board of Directors. Dr. Debrabandere has been an executive officer of the Company since July 2006. Dr. Mills concurrently resigned from the Company's Board of Directors.

Dr. Mills' compensation ceased upon the termination of his employment, consistent with the Company's usual employment practices. There have been no changes to Dr. Debrabandere's compensation at this time.


  Add OSIR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for OSIR - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.